RKDA official logo RKDA
RKDA 1-star rating from Upturn Advisory
Arcadia Biosciences Inc (RKDA) company logo

Arcadia Biosciences Inc (RKDA)

Arcadia Biosciences Inc (RKDA) 1-star rating from Upturn Advisory
$3.65
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/04/2025: RKDA (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $12

1 Year Target Price $12

Analysts Price Target For last 52 week
$12 Target price
52w Low $2.53
Current$3.65
52w High $6.44

Analysis of Past Performance

Type Stock
Historic Profit -54.53%
Avg. Invested days 27
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/04/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 5.03M USD
Price to earnings Ratio -
1Y Target Price 12
Price to earnings Ratio -
1Y Target Price 12
Volume (30-day avg) 1
Beta 0.48
52 Weeks Range 2.53 - 6.44
Updated Date 12/4/2025
52 Weeks Range 2.53 - 6.44
Updated Date 12/4/2025
Dividends yield (FY) -
Basic EPS (TTM) -3.69

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-11-10
When -
Estimate -0.54
Actual 0.62

Profitability

Profit Margin -97.95%
Operating Margin (TTM) -88.48%

Management Effectiveness

Return on Assets (TTM) -31.48%
Return on Equity (TTM) -64.65%

Valuation

Trailing PE -
Forward PE 36.63
Enterprise Value 593893
Price to Sales(TTM) 0.97
Enterprise Value 593893
Price to Sales(TTM) 0.97
Enterprise Value to Revenue 0.11
Enterprise Value to EBITDA 0.62
Shares Outstanding 1373120
Shares Floating 1361902
Shares Outstanding 1373120
Shares Floating 1361902
Percent Insiders 0.82
Percent Institutions 4.77

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Arcadia Biosciences Inc

Arcadia Biosciences Inc(RKDA) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

Arcadia Biosciences, Inc. was founded in 2004. It focuses on developing and marketing crop traits and products aimed at improving human and environmental well-being. Initially focused on traits for crops like wheat and soybeans, it has shifted towards consumer-facing products and ingredients.

Company business area logo Core Business Areas

  • GoodWheat: Arcadia's portfolio of wheat varieties with improved characteristics such as high fiber and reduced gluten. These are sold to food companies and consumers.
  • Arcadia Consumer Health: This segment focuses on consumer products, including Zola coconut water and other health and wellness brands. This segment appears to be divested.
  • CBD: While previously exploring CBD-related opportunities, it appears Arcadia has divested from this and focuses on their GoodWheat product line

leadership logo Leadership and Structure

The leadership team includes Stan Jacot as CEO. The organizational structure is typical of a publicly traded company, with a board of directors overseeing management.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • GoodWheat: GoodWheat offers various traits like high fiber and reduced gluten in wheat. Market share information specific to GoodWheat is difficult to ascertain. Competitors include traditional wheat breeders and companies focused on modifying crop traits for health benefits. Revenue figures fluctuate but are the core revenue driver. Large competitors in the broader crop trait space are companies like Bayer and Corteva.

Market Dynamics

industry overview logo Industry Overview

The agricultural biotechnology industry is characterized by innovation in crop traits, increasing demand for healthier and more sustainable food options, and regulatory scrutiny. It is also marked by increasing competition and consolidation. Consumer preferences for healthier ingredients drive demand.

Positioning

Arcadia Biosciences is positioned as a developer of innovative crop traits and consumer products that address health and sustainability. Its competitive advantage lies in its proprietary technologies and focused product portfolio. It is smaller than its large competitors.

Total Addressable Market (TAM)

The total addressable market for enhanced wheat varieties is substantial, driven by the global consumption of wheat. Exact figures are hard to quantify. Arcadia is positioning itself to capture a segment of this market through its GoodWheat products.

Upturn SWOT Analysis

Strengths

  • Proprietary wheat technology
  • Focus on healthier food options
  • Consumer-facing brand
  • Strong IP portfolio

Weaknesses

  • Limited financial resources
  • Reliance on a narrow product portfolio
  • Relatively small scale of operations
  • History of losses

Opportunities

  • Growing demand for healthier food
  • Expanding partnerships with food companies
  • Further development of wheat traits
  • Increasing consumer awareness

Threats

  • Competition from larger agricultural companies
  • Regulatory hurdles for genetically modified crops
  • Fluctuations in commodity prices
  • Changing consumer preferences

Competitors and Market Share

Key competitor logo Key Competitors

  • BGNE
  • DWAC
  • INPX
  • SENS

Competitive Landscape

Arcadia faces significant competition from larger, more established agricultural companies. It must differentiate itself through innovative products and strategic partnerships.

Growth Trajectory and Initiatives

Historical Growth: Historical growth has been inconsistent, with periods of expansion followed by contractions.

Future Projections: Future growth projections are dependent on successful commercialization of its GoodWheat products and the company's ability to secure partnerships. Analyst estimates are needed for accurate projections.

Recent Initiatives: Recent initiatives focus on expanding the distribution and use of its GoodWheat products in various food applications.

Summary

Arcadia Biosciences is a small company with innovative wheat products aimed at health-conscious consumers. It has struggled with profitability and faces intense competition. The success of the company depends on the adoption of their GoodWheat products and the execution of their commercial strategies. They need to shore up financials.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Arcadia Biosciences Investor Relations
  • SEC Filings
  • Third-party market research reports
  • Yahoo Finance

Disclaimers:

This analysis is based on publicly available information and is for informational purposes only. It should not be considered financial advice. Market share data is often estimated and may not be precise.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Arcadia Biosciences Inc

Exchange NASDAQ
Headquaters Dallas, TX, United States
IPO Launch date 2015-05-15
CEO, Interim CFO, Principal Accounting Officer, President & Director Mr. Thomas J. Schaefer C.F.A.
Sector Consumer Defensive
Industry Packaged Foods
Full time employees 9
Full time employees 9

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.